<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40835367</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-3597</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of the American College of Cardiology</Title><ISOAbbreviation>J Am Coll Cardiol</ISOAbbreviation></Journal><ArticleTitle>Long-Term Outcomes After Fractional Flow Reserve vs Intravascular Ultrasound to Guide PCI: The FLAVOUR Trial Extended Follow-Up.</ArticleTitle><Pagination><StartPage>593</StartPage><EndPage>606</EndPage><MedlinePgn>593-606</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacc.2025.06.042</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-1097(25)06972-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The optimal treatment strategy for patients with intermediate coronary stenosis remains uncertain.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to investigate the long-term outcomes of a randomized, open-label, multinational trial comparing fractional flow reserve (FFR)-guided vs intravascular ultrasound (IVUS)-guided treatment strategies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients aged &#x2265;19 years with de novo intermediate coronary stenosis (40%-70%) and target vessel diameters &#x2265;2.5 mm were randomized 1:1 to FFR- or IVUS-guided treatment across 18 sites in Korea and China. The primary endpoint was a composite of all-cause death, myocardial infarction, and any revascularization occurring after the index procedure. Secondary endpoints included individual components of the primary outcome and per vessel outcomes according to treatment type. Extended follow-up continued through September 2024.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between July 2016 and August 2019, 1,682 patients were assigned to the FFR-guided (n = 838) and IVUS-guided (n = 844) groups. Over a median follow-up period of 6.3 years (Q1-Q3: 5.6-6.9 years), the primary outcome occurred in 339 patients (22.0%), with no statistically significant difference between groups (179 [23.1%] for FFR vs 160 [20.9%] for IVUS; HR: 1.15; 95% CI: 0.93-1.42; P = 0.208). The revascularization rate after the index procedure was higher in the FFR group (113 [14.9%] vs 87 [11.8%]; HR: 1.32; 95% CI: 1.00-1.75; P = 0.049), particularly for target vessel revascularization (72 [9.6%] vs 44 [6.2%]; HR: 1.67; 95% CI: 1.15-2.43; P = 0.007). Landmark analysis at 2 years and per vessel analyses indicated that the higher revascularization rate after the index procedure was driven primarily by late (2-7 years) revascularizations in vessels in which percutaneous coronary intervention (PCI) was initially deferred. Nevertheless, the overall rate of target vessel PCI, including procedures at index and during follow-up, was significantly lower in the FFR group (38.8% vs 60.5%; P &lt; 0.001), with no statistically significant differences in the annual cumulative incidence of death or myocardial infarction between groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">FFR-guided and IVUS-guided treatment strategies resulted in comparable long-term outcomes, with no significant difference in patient-oriented composite outcomes. Although FFR-guided treatment was associated with a higher incidence of late target vessel revascularization, the overall target vessel PCI rate, accounting for both the index procedure and revascularization during follow-up, remained significantly lower in the FFR-guided treatment group, with comparable rates of hard outcomes between the 2 groups.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Seokhun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xinyang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Transvascular Implantation Devices Research Institute, Hangzhou, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jinlong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Transvascular Implantation Devices Research Institute, Hangzhou, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Transvascular Implantation Devices Research Institute, Hangzhou, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hahn</LastName><ForeName>Joo-Yong</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Samsung Medical Center, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doh</LastName><ForeName>Joon-Hyung</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Bong-Ki</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Kangwon National University Hospital, Chuncheon, Gangwon-Do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Weon</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Kyung Hee University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jinyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hangzhou First People's Hospital, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Lijiang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Zhejiang Hospital, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Wenbing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiaomin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Ningbo University, Ningbo, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Wenming</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Ningbo University, Ningbo, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Sung Gyun</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Wonju Severance Christian Hospital, Wonju, Gangwon-Do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahk</LastName><ForeName>Seung-Jea</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Ajou University Hospital, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ung</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Yeungnam University Medical Center, Daegu, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Doyeon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Jeehoon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ki</LastName><ForeName>You-Jeong</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Uijeongbu Eulji Medical Center, Uijeongbu, Gyeonggi-Do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Eun-Seok</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nam</LastName><ForeName>Chang-Wook</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Keimyung University Dongsan Hospital, Daegu, Republic of Korea. Electronic address: ncwcv@dsmc.or.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jian'an</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Second Affiliated Hospital of Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Transvascular Implantation Devices Research Institute, Hangzhou, Hangzhou, China. Electronic address: wja@zju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koo</LastName><ForeName>Bon-Kwon</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: bkkoo@snu.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>FLAVOUR Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Cardiol</MedlineTA><NlmUniqueID>8301365</NlmUniqueID><ISSNLinking>0735-1097</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053805" MajorTopicYN="Y">Fractional Flow Reserve, Myocardial</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018084" MajorTopicYN="Y">Ultrasonography, Interventional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023921" MajorTopicYN="Y">Coronary Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">fractional flow reserve</Keyword><Keyword MajorTopicYN="N">intravascular ultrasound</Keyword><Keyword MajorTopicYN="N">long-term outcomes</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures This study was funded by Yuhan Pharmaceutical. The funder had no role in trial design, data collection, analysis, interpretation, or manuscript preparation. Drs Wang and Hu have received an institutional research grant from Boston Scientific. Dr Nam has received an institutional research grant from Abbott. Dr Koo has received institutional research grants from Abbott Vascular, Boston Scientific, Philips, and Yuhan Pharmaceutical. Dr Hahn has received funding from the South Korean National Evidence-Based Healthcare Collaborating Agency, the South Korean Ministry of Health and Welfare, Abbott Vascular, Biosensors, Biotronik, Boston Scientific, Daiichi-Sankyo, Dong-A ST, Hanmi Pharmaceutical, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Koo</LastName><ForeName>Bon-Kwon</ForeName><Initials>BK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Jian'an</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hu</LastName><ForeName>Xinyang</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nam</LastName><ForeName>Chang-Wook</ForeName><Initials>CW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koh</LastName><ForeName>Jin-Sin</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Keehwan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jung</LastName><ForeName>So Dam</ForeName><Initials>SD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>Seokhun</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jinlong</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sun</LastName><ForeName>Yong</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Changling</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhu</LastName><ForeName>Lingjun</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gao</LastName><ForeName>Feng</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dong</LastName><ForeName>Liang</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jinlong</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Shiqiang</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Park</LastName><ForeName>Kyung Woo</ForeName><Initials>KW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kang</LastName><ForeName>Jeehoon</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hwang</LastName><ForeName>Doyeon</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>Seokhun</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hahn</LastName><ForeName>Joo-Yong</ForeName><Initials>JY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Joo Myung</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choi</LastName><ForeName>Ki Hong</ForeName><Initials>KH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cho</LastName><ForeName>Yun-Kyeong</ForeName><Initials>YK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doh</LastName><ForeName>Joon-Hyung</ForeName><Initials>JH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Bong-Ki</ForeName><Initials>BK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huang</LastName><ForeName>Jinyu</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tong</LastName><ForeName>Guoxin</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jiang</LastName><ForeName>Fan</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xu</LastName><ForeName>Wencheng</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Weon</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woo</LastName><ForeName>Jong Shin</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhou</LastName><ForeName>Hao</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Changxi</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Peng</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ye</LastName><ForeName>Sheng</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tang</LastName><ForeName>Lijiang</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Du</LastName><ForeName>Changqing</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jiang</LastName><ForeName>Wenbing</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Hao</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiaomin</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cui</LastName><ForeName>Hanbin</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>He</LastName><ForeName>Wenming</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xie</LastName><ForeName>Yanqing</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahn</LastName><ForeName>Sung Gyun</ForeName><Initials>SG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tahk</LastName><ForeName>Seung-Jea</ForeName><Initials>SJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yoon</LastName><ForeName>Myeong-Ho</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Ung</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shin</LastName><ForeName>Eun-Seok</ForeName><Initials>ES</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ki</LastName><ForeName>You-Jeong</ForeName><Initials>YJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jang</LastName><ForeName>Eun-Chae</ForeName><Initials>EC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Sun Hwa</ForeName><Initials>SH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jo</LastName><ForeName>Jung-Won</ForeName><Initials>JW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zheng</LastName><ForeName>Gang</ForeName><Initials>G</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>12</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>20</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40835367</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2025.06.042</ArticleId><ArticleId IdType="pii">S0735-1097(25)06972-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>